PeptideDeepDive
TB-500 Suppliers in Europe: 3 Compared (2026)
Comparing TB-500 suppliers in Europe requires an additional identity check. Sellers do not always use the name for the same peptide form, so this page examines sequence or molecular identity alongside current prices, batch testing, availability and EU fulfilment.
Baltic Peptides ranks first under this page’s published comparison criteria, but the exact TB-500 identity still needs verification. Its listing combines 5 mg and 10 mg formats, prices from €39.99, stated same-day EU dispatch and a direct Janoshik report for the 10 mg option. Adria Science provides the clearest full-sequence disclosure. NOVA Labs publishes the broadest visible test panel, but its 10 mg vial was marked sold out when checked.
This TB-500 supplier comparison reviews public pages from three European vendors, checked on 18 September 2026. We compared batch documentation, identity and purity methods, lot traceability, listed formats, EU dispatch and purchasing clarity. We did not order these batches, supervise the laboratories or audit the suppliers. Prices, stock and reports can change, so verify the current listing before procurement.
Baltic Peptides
Baltic Peptides ranks first under the criteria used here: public documentation, two listed formats, EU fulfilment, current availability and price. Its page identifies a 43-residue product at approximately 4,963 g/mol and links to a Janoshik report for the 10 mg option. Researchers should still match the supplied lot to the current report.
- Listed formats
- 5 mg and 10 mg listed
- Price checked
- €39.99–€54.99
- Documentation
- 43-residue identity stated; direct Janoshik report observed for 10 mg
TB-500 suppliers in Europe: comparison table
The table records what each supplier publicly displayed when checked. It does not convert supplier claims into independently verified facts. Where a price varies by location or format, the page says to check the current listing rather than presenting a false like-for-like number.
| Supplier | Listed format | Observed price | Published testing | European dispatch | Review signal |
|---|---|---|---|---|---|
| Baltic Peptides Top EU-access pick | 5 mg / 10 mg | €39.99–€54.99 | 43-residue identity stated; direct Janoshik report observed for 10 mg | Lithuania; same-day EU dispatch stated; in stock when checked | No product-specific reviews shown |
| Adria Science Best identity disclosure | 10 mg | €49.90 for 10 mg when checked | 98.6% reported; batch 2025289, assay 12.38 mg; full sequence disclosed | Czech Republic fulfilment stated; low stock when checked | Company-level reviews shown; not product-specific |
| NOVA Labs Documented alternative | 10 mg | €79.99 when checked | Current batch: 99.75% purity, 10.25 mg; HPLC/LC-MS and additional panels shown | Germany; EU/UK tracked shipping stated; sold out when checked | 4.8/5 from five product ratings shown |
Why Baltic Peptides ranks first here
Baltic Peptides receives the highest editorial ranking because it combines two vial formats, the lowest listed entry price, an available product page, Lithuania-based fulfilment and a direct laboratory-report route. Adria Science discloses more explicit sequence detail, while NOVA Labs displays a wider test panel. This is a documentation-and-purchasing assessment, not an independent finding that one material is superior.
Current product and certificate information should be visible before an order, with a route to verify the named laboratory report.
The compound, strength and lot on the vial should correspond to the certificate rather than a generic example report.
Dispatch from within the EU can simplify logistics, but it does not prove quality, legality or suitability for a project.
Useful listings state formats, stock, payment routes, shipping terms and research-use limits without relying on vague quality claims.
Supplier-by-supplier notes
Baltic Peptides
Highest score for current availability, price, format choice, public verification and EU fulfilment.
- Formats
- 5 mg / 10 mg
- Testing
- 43-residue identity stated; Janoshik report observed for 10 mg
- Dispatch
- Lithuania; same-day EU dispatch stated
Adria Science
Best public explanation of the exact peptide form; low stock when checked.
- Formats
- 10 mg
- Testing
- 98.6% reported; batch 2025289 and assay 12.38 mg; full sequence disclosed
- Dispatch
- Czech Republic fulfilment stated
NOVA Labs
Detailed current-batch results and five product ratings, but the listing was sold out and carried the highest observed price.
- Formats
- 10 mg
- Testing
- 99.75% purity and 10.25 mg; HPLC/LC-MS, heavy-metals, endotoxin and sterility panels shown
- Dispatch
- Germany; sold out when checked
TB-500: the brief research context
TB-500 is a supplier label that can create confusion. Published analytical literature has described an N-acetylated LKKTETQ fragment, while some commercial listings use the name for full-length thymosin beta-4. Those are not interchangeable descriptions. A supplier comparison must establish the exact sequence or molecular identity before comparing purity percentages.
This page is intentionally short on general compound background because it serves supplier-comparison intent. For the evidence, limitations and regulatory context, read the TB-500 evidence and identity guide .
What to verify before choosing a TB-500 supplier
- Identify whether the listing is the short Ac-LKKTETQ fragment or full-length thymosin beta-4.
- Compare the stated molecular mass and sequence with the laboratory report.
- Verify both HPLC purity and an orthogonal identity method.
- Check measured vial content instead of relying on the label quantity alone.
- Match the dispatched lot to the current certificate and retain the record.
A COA is evidence about the tested sample and methods shown on that report. It is not proof of clinical safety, regulatory approval, sterility or suitability for human use. HPLC purity alone also does not establish identity, fill quantity, endotoxin status or lot-to-lot consistency.
TB-500 supplier FAQ
Which TB-500 supplier is best in Europe?
Baltic Peptides ranks first under the criteria used here: public documentation, format choice, EU fulfilment, current availability and listed price. Adria Science is especially useful where explicit sequence disclosure is the priority.
Why does TB-500 identity matter?
The term TB-500 is used inconsistently. Some sources describe a short thymosin beta-4 fragment, while some commercial products identify full-length thymosin beta-4. Researchers must verify the exact material.
Is HPLC purity enough for TB-500?
No. HPLC can estimate purity, but researchers also need identity information, ideally supported by molecular-mass or sequence data.
Is TB-500 an approved European medicine?
The suppliers compared here market TB-500 as research-use-only material rather than an authorised medicine. Check current rules and institutional requirements in your country.
Check the current TB-500 batch before ordering
Confirm the strength, lot number, certificate, destination availability and current price on the supplier page. The link below is an affiliate link.
Sources checked
- Baltic Peptides — TB-500 product listing .
- Adria Science — TB-500 sequence, batch and testing information .
- NOVA Labs — TB-500 product, batch results and availability .
- PeptideDeepDive — TB-500 evidence and identity guide .
- Google Search Central — high-quality review guidance .
Editorial note: Supplier pages, prices, stock and certificates can change. This comparison records the public information checked on 18 September 2026. Recheck the current batch before relying on any listing.